Drugs giant AstraZeneca's major setback as bad trial results wipe £10bn from value

Drugs giant AstraZeneca's major setback as bad trial results wipe £10bn from value

- in Forex Trading
14
0

ASTRAZENECA investors felt the pain yesterday as a major setback for a key lung cancer treatment wiped nearly £10billion from the company’s market value.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like

Black Friday 2017: Sneakers and Shoppers

So the Gray Zebra Yeezy Boosts he was